标普生物科技LOF(161127)
动态评分： 4.62分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2020-06-30 | GOSS | Gossamer Bio Inc | 21.91 | 0.21% |
| 2020-06-30 | VIE | Viela Bio Inc | 21.93 | 0.21% |
| 2020-06-30 | KURA | Kura Oncology Inc | 20.54 | 0.2% |
| 2020-06-30 | TCRT | Alaunos Therapeutics Inc | 21.16 | 0.2% |
| 2020-06-30 | RYTM | Rhythm Pharmaceuticals Inc | 19.47 | 0.19% |
| 2020-06-30 | SPPI | Spectrum Pharmaceuticals Inc | 19.27 | 0.19% |
| 2020-06-30 | CTMX | CytomX Therapeutics Inc | 18.96 | 0.18% |
| 2020-06-30 | ASMB | Assembly Biosciences Inc | 18 | 0.17% |
| 2020-06-30 | VYGR | Voyager Therapeutics Inc | 17.82 | 0.17% |
| 2020-06-30 | AVRO | AVROBIO Inc | 16.97 | 0.16% |
| 2020-06-30 | PDLI | PDL BioPharma Inc | 15.07 | 0.15% |
| 2020-06-30 | PRTA | Prothena Corp plc | 12.36 | 0.12% |
| 2020-03-31 | REGN | 再生元制药 | 184.05 | 2.63% |
| 2020-03-31 | MRNA | Moderna Inc | 176.27 | 2.52% |
| 2020-03-31 | GILD | 吉利德科学 | 161.24 | 2.31% |
| 2020-03-31 | VRTX | 福泰制药 | 154.09 | 2.21% |
| 2020-03-31 | BIIB | 生化基因 | 151.08 | 2.16% |
| 2020-03-31 | UTHR | 联合治疗 | 150.09 | 2.15% |
| 2020-03-31 | BMRN | 拜玛林制药 | 149.55 | 2.14% |
| 2020-03-31 | SGEN | Seagen Inc | 143.71 | 2.06% |
公告&资料
